[144] VTEX SEC Filing
Form 144 notice for VTEX (VTEX) indicates a proposed sale of 4,500 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $18,630.00 and an approximate sale date of 09/16/2025. The shares were acquired on 03/19/2019 by previously exercised stock options and paid in cash. The filing lists prior 10b5-1 plan sales by related parties totaling 9,000 shares in July and August 2025 with accompanying gross proceeds shown. The notice includes the standard Rule 144 representation about material nonpublic information and 10b5-1 plan adoption disclosure.
- None.
- None.
Insights
TL;DR: Routine insider sale under Rule 144 and 10b5-1, small in size relative to typical public float; appears procedural rather than material.
The filing documents a proposed sale of 4,500 shares acquired via exercised options in 2019, to be executed through Morgan Stanley Smith Barney on the NYSE. The filing also discloses recent 10b5-1 sales aggregating 9,000 shares across July and August 2025 with listed gross proceeds. No earnings, debt, or corporate action details are included, and the filer certifies absence of undisclosed material information. For investors, this is a disclosure of insider liquidity rather than operational developments.
TL;DR: Disclosure aligns with compliance expectations for Rule 144 and 10b5-1 sales; signature attests to absence of material nonpublic information.
The submission identifies the nature of acquisition (previously exercised stock options) and the payment method (cash), fulfilling Form 144 requirements. It also lists broker details and dates for both the proposed sale and recent 10b5-1 transactions by related parties. There is no indication of irregularities or deviations from standard reporting protocols in the provided content.